Covered recipient · General Payments record
SHERYL HAYNES
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2019–2024
$5,415.15
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $503.45 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $330.30 | 11 |
| Corcept Therapeutics | $56.63 | 3 |
| Abbott Laboratories | $44.14 | 2 |
| Lilly USA, LLC | $38.40 | 2 |
| SHIELD THERAPEUTICS INC | $18.51 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $15.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.29 | 02/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125179958 | CMS |
| Abbott Laboratories | $23.85 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125179960 | CMS |
| ABBVIE INC. | $10.94 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895882 | CMS |
| ABBVIE INC. | $7.48 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895884 | CMS |
| ABBVIE INC. | $125.00 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895886 | CMS |
| ABBVIE INC. | $33.92 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895888 | CMS |
| ABBVIE INC. | $12.25 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895890 | CMS |
| ABBVIE INC. | $25.24 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895892 | CMS |
| ABBVIE INC. | $8.77 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895894 | CMS |
| ABBVIE INC. | $22.93 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895896 | CMS |
| ABBVIE INC. | $32.38 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895898 | CMS |
| ABBVIE INC. | $30.74 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895900 | CMS |
| ABBVIE INC. | $20.65 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103895902 | CMS |
| Corcept Therapeutics | $19.31 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117758225 | CMS |
| Corcept Therapeutics | $18.81 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117758279 | CMS |
| Corcept Therapeutics | $18.51 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117758299 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $15.47 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146772012 | CMS |
| Lilly USA, LLC | $19.14 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135376564 | CMS |
| Lilly USA, LLC | $19.26 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135425631 | CMS |
| SHIELD THERAPEUTICS INC | $18.51 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150156365 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.